Eye disorders affect a substantial portion of the global population, yet the availability of
efficacious ophthalmic drug products remains limited. This can be partly ascribed to a …

Injectable hydrogels based on biopolymers, fabricated utilizing diverse chemical and
physical methodologies, exhibit exceptional physical, chemical, and biological properties …

In situ gels have been developed as an innovative strategy to prolong corneal residence
time and enhance drug absorption compared to traditional eye drops. Our study aimed to …

Ocular disorders, encompassing both common ailments like dry eye syndrome and more
severe situations for instance age-related macular degeneration, present significant …

Dexamethasone (DXM) is a commonly used corticosteroid in the treatment of ocular
inflammatory conditions that affect more and more people. The aim of this study was to …

In recent years, stimulus-sensitive drug delivery systems have been developed for
parenteral administration as a depot system. In situ systems incorporate smart polymers that …

Ocular drug delivery systems play a critical role in the treatment of various eye diseases via
ensuring targeted and efficient delivery of therapeutic agent. The complex anatomy and …

The present investigation on nanoliposome infused with oxymetazoline hydrochloride was
fabricated with phosphatidylcholine and cholesterol to effectively deliver the drug to the skin …

Liposomal technology has become a significant advancement in the field of veterinary
therapeutics, offering increased performance and safety in the delivery of treatments such as …

The present study aimed to develop and assess an in situ gel formulation of Nepafenac for
treating ocular pain and inflammation. The in situ gel was created using different polymer …